Kelsch T, Kikuchi K, Vahdat S, Frishman W H
Department of Medicine, New York Medical College, Westchester County Medical Center, Valhalla, New York, USA.
Heart Dis. 2001 Jan-Feb;3(1):46-54. doi: 10.1097/00132580-200101000-00007.
The survival rate of patients undergoing cardiopulmonary resuscitation is 5 to 15%. New cardiopulmonary resuscitation treatment approaches under investigation include the use of vasopressin as a vasopressor, amiodarone for the treatment of ventricular tachyarrhythmias, and adenosine antagonists (i.e., theophylline) for bradyasystolic rhythms. More innovative approaches include the use of thyroid hormone and endothelin.
接受心肺复苏的患者存活率为5%至15%。正在研究的新的心肺复苏治疗方法包括使用血管加压素作为血管收缩剂、使用胺碘酮治疗室性快速心律失常以及使用腺苷拮抗剂（即茶碱）治疗缓慢性心搏停止节律。更具创新性的方法包括使用甲状腺激素和内皮素。
